Paper37628906
Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y and 5 others. Int J Mol Sci, 2023. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. Papers, record 37628906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37628906
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Pyrazoles | |
| Cell Line | |
| Structure-Activity Relationship | |
| Tubulin |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22207027 | NFSC | PubMed | ||
| LQ22B020003 | Fund Committee of Zhejiang Province | PubMed | ||
| 2021QDL041 | Hangzhou Normal University | PubMed |
Source PubMed
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29031622 | Haspin: a promising target for the design of inhibitors as potent anticancer drugs. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/29031622 | PubMed |
| 2 | 30849534 | The relation between PI3K/AKT signalling pathway and cancer. | Gene | 2019 | https://conductscience.org/library/papers/30849534 | PubMed |
| 3 | 29567429 | Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma. | Bioorg Chem | 2018 | https://conductscience.org/library/papers/29567429 | PubMed |
| 4 | 35741451 | Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35741451 | PubMed |
| 5 | 27653758 | Apixaban: A Review in Venous Thromboembolism. | Drugs | 2016 | https://conductscience.org/library/papers/27653758 | PubMed |
| 6 | 18852116 | Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/18852116 | PubMed |
| 7 | 29268127 | Design, synthesis and biological evaluation of 1, 4-dihydro indeno[1,2-c] pyrazole linked oxindole analogues as potential anticancer agents targeting tubulin and inducing p53 dependent apoptosis. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/29268127 | PubMed |
| 8 | 30149323 | Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/30149323 | PubMed |
| 9 | 32039146 | Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors. | Front Chem | 2019 | https://conductscience.org/library/papers/32039146 | PubMed |
| 10 | 34818572 | Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative. | Eur J Pharm Sci | 2022 | https://conductscience.org/library/papers/34818572 | PubMed |
| 11 | 30006168 | Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/30006168 | PubMed |
| 12 | 30606674 | Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. | Bioorg Med Chem | 2019 | https://conductscience.org/library/papers/30606674 | PubMed |
| 13 | 30332801 | Anticancer and Anti-Inflammatory Activities of Some New Pyrazolo[3,4-b]pyrazines. | Molecules | 2018 | https://conductscience.org/library/papers/30332801 | PubMed |
| 14 | 32559576 | Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32559576 | PubMed |
| 15 | 30221233 | Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores and Structure Activity Studies for Tubulin Polymerization. | ACS Omega | 2018 | https://conductscience.org/library/papers/30221233 | PubMed |
| 16 | 30981111 | Targeting hepatocellular carcinoma: Synthesis of new pyrazole-based derivatives, biological evaluation, DNA binding, and molecular modeling studies. | Bioorg Chem | 2019 | https://conductscience.org/library/papers/30981111 | PubMed |
| 17 | 29433928 | Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/29433928 | PubMed |
| 18 | 29232583 | Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/29232583 | PubMed |
| 19 | 36411633 | Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36411633 | PubMed |
| 20 | 36067564 | Mechanism and inhibition of BRAF kinase. | Curr Opin Chem Biol | 2022 | https://conductscience.org/library/papers/36067564 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653326 | Dual Anticancer and Antibacterial Applications of Active Particle Aggregates Containing Metal Phthalocyanines in Dark. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653326 | PubMed |
| 42515760 | Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515760 | PubMed |
| 42357430 | Heteroaromatic Pyrazole-Based Carbohydrazones: Structure-Dependent Redox Activity, DNA-Associated Spectroscopic Behavior, and Multifunctional Biological Properties. | Molecules | 2026 | https://conductscience.org/library/papers/42357430 | PubMed |
| 42225755 | Targeting colorectal cancer with pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides: comprehensive in vitro evaluation. | Sci Rep | 2026 | https://conductscience.org/library/papers/42225755 | PubMed |
| 42147720 | Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance. | Cancer Drug Resist | 2026 | https://conductscience.org/library/papers/42147720 | PubMed |
| 42130847 | Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines. | RSC Adv | 2026 | https://conductscience.org/library/papers/42130847 | PubMed |
| 42074046 | The Pyrazole Scaffold in Anticancer Drug Discovery: A Review of Synthetic Approaches, Structure-Activity Relationships, and Target-Based Mechanism of Action. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074046 | PubMed |
| 41930163 | Discovery of Two Novel Pyrazole Derivatives as Anticancer Agents Targeting Tubulin Polymerization and MAPK Signaling Pathways. | Oncol Res | 2026 | https://conductscience.org/library/papers/41930163 | PubMed |
| 41901229 | Synthesis and Development of 3-((2,4-Difluorophenyl)Amino)Propanoic Acid Derivatives as an Antiproliferative Medicinal Chemistry Scaffold Targeting Growth Factor Receptors. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901229 | PubMed |
| 41841329 | Multi-targeted pyrazole scaffolds: synthesis, mechanistic insights, and therapeutic potential in anticancer, antioxidant, and anti-inflammatory applications. | Libyan J Med | 2026 | https://conductscience.org/library/papers/41841329 | PubMed |
| 41754878 | Azole-Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754878 | PubMed |
| 41599605 | Synthesis, Characterization, Antimicrobial and Anticancer Evaluation of Novel Heterocyclic Diazene Compounds Derived from 8-Quinolinol. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599605 | PubMed |
| 41575480 | Recent advances in carbonyl infused bis-pyrazoles: relevance, synthetic developments and biological significance. | Mol Divers | 2026 | https://conductscience.org/library/papers/41575480 | PubMed |
| 41548057 | Molecular Hybridization Strategy for Developing Lipid-Lowering Compounds: Design and Synthesis of Vanillin-Based Fibrate Derivatives. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/41548057 | PubMed |
| 41226375 | Switching N-Alkylation Regioselectivity of Trifluoromethylated Pyrazoles Guided by Functional Group Tuning. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226375 | PubMed |
| 41053951 | Preparation of Hierarchically Structured Perlite NPs/Metformin-Co (II) System to Catalyze the Green Synthesis of Pyrazolopyranopyrimidines. | ChemistryOpen | 2025 | https://conductscience.org/library/papers/41053951 | PubMed |
| 40985933 | Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression-A Comprehensive Review. | Phytother Res | 2025 | https://conductscience.org/library/papers/40985933 | PubMed |
| 40807478 | Synthesis and Biological Evaluation of β-Phenylalanine Derivatives Containing Sulphonamide and Azole Moieties as Antiproliferative Candidates in Lung Cancer Models. | Molecules | 2025 | https://conductscience.org/library/papers/40807478 | PubMed |
| 40649394 | Synthesis of Novel Tetra-Substituted Pyrazole Derivatives Using Microwave Irradiation and Their Anti-Leukemic Activity Against Jurkat Cells. | Molecules | 2025 | https://conductscience.org/library/papers/40649394 | PubMed |
| 40511659 | A Review of Research from 2012 to 2024 on Pyrazole-based Anticancer Agents with SAR Study. | Curr Top Med Chem | 2026 | https://conductscience.org/library/papers/40511659 | PubMed |
Genes57
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37628906
GET https://conductscience.org/api/papers/v1/37628906/references?page=2